13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001974915
Total reported value
$4.3B
$4.3B
58 檔
12.0%
The Q1 2024 SEC filing reveals that Vestal Point Capital, LP held a total portfolio value of $4.3B, covering 58 public equity positions.
During Q1 2024, Vestal Point Capital, LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including CYTK, JAZZ, NBIX) accounted for 12.0% of total reported equity market value during Q1 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CYTK | Cytokinetics Inc | Stock-Healthcare | 12.47% | -0.55% | EXIT | |
| 2 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 10.95% | — | +51.72% | |
| 3 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 8.10% | +2.80% | -11.25% | |
| 4 | ASND | Ascendis Pharma A/S | Stock-Other | 6.56% | -2.40% | EXIT | |
| 5 | GMED | Globus Medical Inc - A | Stock-Healthcare | 4.44% | +0.10% | +25.00% | |
| 6 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 4.42% | -0.68% | EXIT | |
| 7 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 4.33% | — | +900.00% | |
| 8 | ONC | Beone Medicines Ltd-adr | Stock-Other | 4.20% | — | — | |
| 9 | NARIUSD | Inari Medical Inc | Stock-Other | 3.17% | — | — | |
| 10 | APLT | Applied Therapeutics Inc | Stock-Other | 2.87% | — | +22.98% | |
| 11 | LQDA | Liquidia CORP | Stock-Other | 2.44% | — | +95.12% | |
| 12 | ALXO | Alx Oncology Holdings Inc | Stock-Other | 2.41% | — | +57.70% | |
| 13 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.24% | — | +60.00% | |
| 14 | QURE | uniQure N.V. | Stock-Other | 2.03% | +0.85% | +20.38% | |
| 15 | INSM | Insmed Inc | Stock-Healthcare | 1.68% | +0.62% | NEW | |
| 16 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.63% | — | — | |
| 17 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 1.42% | -0.05% | +128.57% | |
| 18 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 1.32% | — | — | |
| 19 | CATBUSD | Astria Therapeutics Inc | Stock-Other | 1.28% | — | — | |
| 20 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.26% | +2.41% | — | |
| 21 | NVLSEUR | Alpine Immune Sciences Inc | Stock-Other | 1.15% | — | — | |
| 22 | SLDB | Solid Biosciences Inc | Stock-Other | 1.14% | -0.51% | +2936.53% | |
| 23 | DNTH | Dianthus Therapeutics Inc | Stock-Other | 1.13% | — | +237.04% | |
| 24 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 1.09% | — | — | |
| 25 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.07% | — | — | |
| 26 | PRAX | Praxis Precision Medicines I | Stock-Other | 1.06% | — | — | |
| 27 | ✓ | Immatics NV | Stock-Other | 1.04% | -0.24% | -42.86% | |
| 28 | INCY | Incyte CORP | Stock-Healthcare | 0.94% | — | — | |
| 29 | MGNX | Macrogenics Inc | Stock-Other | 0.88% | -0.02% | EXIT | |
| 30 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 0.79% | -0.43% | EXIT | |
| 31 | SWAVUSD | Shockwave Medical Inc | Stock-Other | 0.67% | — | — | |
| 32 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.66% | — | — | |
| 33 | 4XC1 | Kalvista Pharmaceuticals Inc | Stock-Other | 0.64% | -1.04% | EXIT | |
| 34 | GERN | Geron CORP | Stock-Other | 0.60% | -0.11% | EXIT | |
| 35 | ACLXGBX | Arcellx Inc | Stock-Other | 0.58% | — | +66.67% | |
| 36 | EXK | Exact Sciences CORP | Stock-Materials | 0.57% | — | — | |
| 37 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 0.54% | -0.24% | EXIT | |
| 38 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.51% | -0.21% | — | |
| 39 | ✓ | Passage Bio Inc | Stock-Other | 0.50% | — | — | |
| 40 | ALLO | Allogene Therapeutics Inc | Stock-Other | 0.50% | — | — | |
| 41 | FATE | Fate Therapeutics Inc | Stock-Other | 0.49% | — | -37.98% | |
| 42 | VYGR | Voyager Therapeutics Inc | Stock-Other | 0.46% | -0.11% | — | |
| 43 | RLMD | Relmada Therapeutics Inc | Stock-Other | 0.46% | — | +943.48% | |
| 44 | BIO | Bio-rad Laboratories-a | Stock-Healthcare | 0.43% | — | — | |
| 45 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.42% | — | — | |
| 46 | LYRAGBP | Lyra Therapeutics Inc | Stock-Other | 0.41% | — | -73.33% | |
| 47 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 0.35% | — | — | |
| 48 | ANRO | Alto Neuroscience Inc | Stock-Other | 0.32% | -0.82% | — | |
| 49 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.23% | -0.25% | — | |
| 50 | PRME | Prime Medicine Inc | Stock-Other | 0.21% | — | +1672.88% |
According to official SEC Form 13F filings, Vestal Point Capital, LP reported a total U.S. public equity portfolio value of $4.3B across 58 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
During Q1 2024, Vestal Point Capital, LP's top holdings by market value included CYTK (12.5%)、JAZZ (10.9%)、NBIX (8.1%). The largest single position, CYTK, represented 12.5% of total portfolio value.
In Q1 2024, Vestal Point Capital, LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.